New Board members will provide expert insight into ADME-Tox, biomarker, assay, cell and gene therapy, and immuno-oncology advances.

As BIVDA attended the APPG for Life Sciences event based on the new ‘Data Saves Lives’ Strategy this week, we have provided some information on the action plan for members.The Strategy aims to reshape health and social care through more effective use of data, increased trust from the public in health data provision, leveraging technologies to allow better access to care records for patients and ultimately, swifter treatment and improved patient outcomes.Some of the key tenets of the ...

The Crown Commercial Service (CCS), the UK’s largest public procurement organisation, is working in partnership with NHS England and the Department of Health and Social Care (DHSC) to provide Atamis software licences to support health sector buyers, procurement teams, data analysts, and commercial teams to adopt the e-commerce system.Following the launch of the NHS Central Commercial Function (CCF), at Public Board on 7th July, the rollout of Atamis will provide greater insight into procur...

A webinar was held on 6 July 2022 on how diagnostics companies should respond to new NHS systems and policies, and the new integrated care systems (ICS). The event featured expert advice from Shailen Rao (Managing Director of Soar Beyond) and BIVDA COO Helen Dent.BIVDA members can find the recording of the webinar through this YouTube link here: https://youtu.be/ySVYC30pSVc 

BSI, BEIS and the Race to Zero campaign are working together to supply 100,000 free copies to help small and medium-sized businesses reach Net Zero.

Please click here for important updates on these topics.

The Bill is seeking to tear up trade rules set out in the Protocol and replace these with a two-stream system of goods flow via or towards Northern Ireland.

The North East Innovation Lab has played a key role in a successful study to develop a new biosensor which could be used in Covid-19 diagnostic tests.

BIVDA welcomes MHRA’s formal response to the consultation on future regulation of medical devices in the UK The response to the consultation on the new UK Regulatory Framework for medical devices was published on 26 June 2022. This is a huge step for regulation in the UK and gives an insight into what can be expected when the regulations are published. Totalling 16 chapters and spanning 155 pages, the response is very comprehensive and detailed. This depth has been anticipated by the ...

New data has been made available on patient wait times for tests, diagnostic activities and referrals.